British AI biotech spin-off of DeepMind
Google has reorganised its AI leadership: Demis Hassabis has stepped back from day-to-day running of DeepMind to become its chair and Alphabet chief scientist, and Koray Kavukcuoglu has been promoted to senior vice-president to run Google DeepMind. Several senior engineers, including Jeff Dean and Sanjay Ghemawat, have left to launch a new startup; Alphabet shares have fallen.
Arm Holdings chief executive Rene Haas says AI could one day help cure cancer, but the path is constrained by chip shortages and a demand surge for AI data centres. Multiple outlets report Haas’s remarks, framing a broaderAI-driven push in healthcare and manufacturing, while flagging supply constraints and broader market excitement.
Anthropic has built a wet lab in the San Francisco Bay Area to accelerate biology work, confirming a shift from in silico research to real-lab experimentation. The move comes amid warnings about AI risks and a looming IPO, with leadership stressing safety while pursuing faster drug development.
Nvidia, AMD, OpenAI, Anthropic and Google have pledged billions to fund the Genesis Mission, an AI initiative across 15 federal agencies to accelerate research. The White House says the program will provide AI tools and compute credits, with Nvidia alone contributing $1 billion. The funding aims to speed breakthroughs in medicine, energy and space.